The type 1 HDACi RGFP109/RG2833 is thought to be targeting HDAC1 and HDAC3, the likes of which were previously shown to increase the expression of the frataxin gene in FA patient peripheral blood mononuclear cells[32]. This evidence concerns the gene HDAC3 and Friedreich ataxia.